Founded in 1978, Par Pharma carries around 127 generic drugs. It has manufacturing and packaging facilities in both the United States and in India, through the acquisition of the India-based contract research organization Ethics Bio Lab. Par Pharma is an operating company of Endo International. The company has 4 manufacturing sites in U.S. (New York, California, Michigan); 5 facilities in India.